P5090Sortilin is a key driver of fibrocalcific aortic valve disease Article

Schlotter, F, Goettsch, C, Rogers, MA et al. (2018). P5090Sortilin is a key driver of fibrocalcific aortic valve disease . EUROPEAN HEART JOURNAL, 39(suppl_1), ehy566.p5090. 10.1093/eurheartj/ehy566.p5090

cited authors

  • Schlotter, F; Goettsch, C; Rogers, MA; Hutcheson, JD; Blaser, MC; Goto, S; Lee, LH; Delaughter, DM; Merryman, WD; Seidman, JG; Jaffer, FA; Body, SC; Aikawa, M; Singh, SA; Aikawa, E

authors

publication date

  • August 1, 2018

published in

keywords

  • 32 Biomedical and Clinical Sciences
  • 3201 Cardiovascular Medicine and Haematology
  • 3202 Clinical Sciences

Digital Object Identifier (DOI)

publisher

  • Oxford University Press (OUP)

start page

  • ehy566.p5090

volume

  • 39

issue

  • suppl_1